Receipt of infant HIV DNA PCR test results is associated with a reduction in retention of HIV-exposed infants in integrated HIV care and healthcare services: a quantitative sub-study nested within a cluster randomised trial in rural Malawi.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
07 Dec 2020
Historique:
received: 30 04 2020
accepted: 25 11 2020
entrez: 8 12 2020
pubmed: 9 12 2020
medline: 7 5 2021
Statut: epublish

Résumé

Retention of HIV-infected mothers in integrated HIV and healthcare facilities is effective at reducing mother-to-child-transmission (MTCT) of HIV. In the context of Option B+, we examined maternal and HIV-exposed infant retention across three study arms to 18 months postpartum: mother-and-infant clinics (MIP), MIP with short-messaging service (MIP + SMS) and standard of care (SOC). In particular, we focused on the impact of mothers receiving an infant's HIV PCR test result on maternal and infant study retention. A quantitative sub-study nested within a cluster randomised trial undertaken between May 2013 and August 2016 across 30 healthcare facilities in rural Malawi enrolling HIV-infected pregnant mothers and HIV-exposed infants on delivery, was performed. Survival probabilities of maternal and HIV-exposed infant study retention was estimated using Kaplan-Meier curves. Associations between mother's receiving an infant's HIV test result and in particular, an infant's HIV-positive result on maternal and infant study retention were modelled using time-varying multivariate Cox regression. Four hundred sixty-one, 493, and 396 HIV-infected women and 386, 399, and 300 HIV-exposed infants were enrolled across study arms; MIP, MIP + SMS and SOC, respectively. A total of 47.5% of mothers received their infant's HIV test results < 5 months postpartum. Receiving an infant's HIV result by mothers was associated with a 70% increase in infant non-retention in the study compared with not receiving an infant's result (HR = 1.70; P-value< 0.001). Receiving a HIV-positive result was associated with 3.12 times reduced infant retention compared with a HIV-negative result (P-value< 0.001). Of the infants with a HIV-negative test result, 87% were breastfed at their final study follow-up. Receiving an infant's HIV test result was a driving factor for reduced infant study retention, especially an infant's HIV-positive test result. As most HIV-negative infants were still breastfed at their last follow-up, this indicates a large proportion of HIV-exposed infants were potentially at future risk of MTCT of HIV via breastfeeding but were unlikely to undergo follow-up HIV testing after breastfeeding cessation. Future studies to identify and address underlying factors associated with infant HIV testing and reduced infant retention could potentially improve infant retention in HIV/healthcare facilities. Pan African Clinical Trial Registry: PACTR201312000678196 .

Sections du résumé

BACKGROUND BACKGROUND
Retention of HIV-infected mothers in integrated HIV and healthcare facilities is effective at reducing mother-to-child-transmission (MTCT) of HIV. In the context of Option B+, we examined maternal and HIV-exposed infant retention across three study arms to 18 months postpartum: mother-and-infant clinics (MIP), MIP with short-messaging service (MIP + SMS) and standard of care (SOC). In particular, we focused on the impact of mothers receiving an infant's HIV PCR test result on maternal and infant study retention.
METHODS METHODS
A quantitative sub-study nested within a cluster randomised trial undertaken between May 2013 and August 2016 across 30 healthcare facilities in rural Malawi enrolling HIV-infected pregnant mothers and HIV-exposed infants on delivery, was performed. Survival probabilities of maternal and HIV-exposed infant study retention was estimated using Kaplan-Meier curves. Associations between mother's receiving an infant's HIV test result and in particular, an infant's HIV-positive result on maternal and infant study retention were modelled using time-varying multivariate Cox regression.
RESULTS RESULTS
Four hundred sixty-one, 493, and 396 HIV-infected women and 386, 399, and 300 HIV-exposed infants were enrolled across study arms; MIP, MIP + SMS and SOC, respectively. A total of 47.5% of mothers received their infant's HIV test results < 5 months postpartum. Receiving an infant's HIV result by mothers was associated with a 70% increase in infant non-retention in the study compared with not receiving an infant's result (HR = 1.70; P-value< 0.001). Receiving a HIV-positive result was associated with 3.12 times reduced infant retention compared with a HIV-negative result (P-value< 0.001). Of the infants with a HIV-negative test result, 87% were breastfed at their final study follow-up.
CONCLUSIONS CONCLUSIONS
Receiving an infant's HIV test result was a driving factor for reduced infant study retention, especially an infant's HIV-positive test result. As most HIV-negative infants were still breastfed at their last follow-up, this indicates a large proportion of HIV-exposed infants were potentially at future risk of MTCT of HIV via breastfeeding but were unlikely to undergo follow-up HIV testing after breastfeeding cessation. Future studies to identify and address underlying factors associated with infant HIV testing and reduced infant retention could potentially improve infant retention in HIV/healthcare facilities.
TRIAL REGISTRATION BACKGROUND
Pan African Clinical Trial Registry: PACTR201312000678196 .

Identifiants

pubmed: 33287772
doi: 10.1186/s12889-020-09973-y
pii: 10.1186/s12889-020-09973-y
pmc: PMC7720620
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1879

Subventions

Organisme : National Health and Medical Research Council
ID : APP1120081

Références

Bull World Health Organ. 2012 Sep 1;90(9):699-704
pubmed: 22984315
J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S120-4
pubmed: 25310117
J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S123-S131
pubmed: 28498181
BMJ. 2011 Sep 26;343:d5886
pubmed: 21948873
Trop Med Int Health. 2005 Dec;10(12):1242-50
pubmed: 16359404
BMJ Open. 2019 Jul 29;9(7):e024907
pubmed: 31362959
J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S132-S139
pubmed: 28498182
Arch Dis Child. 2010 Jun;95(6):414-21
pubmed: 19880392
PLoS One. 2013;8(3):e57778
pubmed: 23554867
PLoS One. 2017 Jan 6;12(1):e0169497
pubmed: 28060886
BMC Infect Dis. 2018 Aug 22;18(1):416
pubmed: 30134851
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1285-1290
pubmed: 27880749
PLoS One. 2014 Mar 06;9(3):e86461
pubmed: 24603442
PLoS One. 2017 Apr 14;12(4):e0175590
pubmed: 28410374
J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S140-S148
pubmed: 28498183
Int J Epidemiol. 2011 Apr;40(2):385-96
pubmed: 21247884
AIDS. 2013 Nov 13;27(17):2787-97
pubmed: 24056068
BMC Public Health. 2020 Mar 6;20(1):298
pubmed: 32143666

Auteurs

Elasma Milanzi (E)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia.
Victorian Centre for Biostatistics, Melbourne, Victoria, Australia.

Victor Mwapasa (V)

College of Medicine, University of Malawi, Blantyre, Malawi.

Jessica Joseph (J)

Clinton Health Access Initiative (CHAI), MA, Boston, USA.

Aurelie Jousset (A)

Clinton Health Access Initiative (CHAI), Lilongwe, Malawi.

Timothy Tchereni (T)

Clinton Health Access Initiative (CHAI), Lilongwe, Malawi.

Andrews Gunda (A)

Clinton Health Access Initiative (CHAI), Lilongwe, Malawi.

Jennipher Phiri (J)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia.

Jeanette C Reece (JC)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia. jreece@unimelb.edu.au.
The University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, Victoria, Australia. jreece@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH